524768 EMMESSA

Emmessar Biotech & Nutrition Share Price

₹34.00 +1.41 (4.33%)

17 Jun, 2025 10:56

SIP TrendupStart SIP in EMMESSA

Start SIP

Performance

  • Low
  • ₹31
  • High
  • ₹37
  • 52 Week Low
  • ₹27
  • 52 Week High
  • ₹64
  • Open Price₹31
  • Previous Close₹33
  • Volume372

Investment Returns

  • Over 1 Month -1.45%
  • Over 3 Month + 4.62%
  • Over 6 Month -24.31%
  • Over 1 Year -12.82%
SIP Lightning

Smart Investing Starts Here Start SIP with Emmessar Biotech & Nutrition for Steady Growth!

Invest Now

Emmessar Biotech & Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 53.7
  • PEG Ratio
  • -0.9
  • Market Cap Cr
  • 17
  • P/B Ratio
  • 2.2
  • Average True Range
  • 2.53
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.26
  • RSI
  • 44.99
  • MFI
  • 44.34

Emmessar Biotech & Nutrition Financials

Emmessar Biotech & Nutrition Technicals

EMA & SMA

Current Price
₹34.00
+ 1.41 (4.33%)
pointer
  • stock-down_img
  • Bearish Moving Average 7
  • stock-up_img
  • Bullish Moving Average 9
  • 20 Day
  • ₹33.51
  • 50 Day
  • ₹34.04
  • 100 Day
  • ₹35.43
  • 200 Day
  • ₹36.97

Resistance and Support

32.38 Pivot Speed
  • R3 34.23
  • R2 33.54
  • R1 33.07
  • S1 31.91
  • S2 31.22
  • S3 30.75

What's your outlook on Emmessar Biotech & Nutrition?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emmessar Biot.& Nut. has an operating revenue of Rs. 0.61 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 157% is great, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 14 which is a POOR score indicating inconsistency in earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emmessar Biotech & Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-04-24 Audited Results
2025-02-06 Quarterly Results
2024-11-07 Quarterly Results
2024-08-14 Quarterly Results
2024-05-29 Audited Results

Emmessar Biotech & Nutrition F&O

Emmessar Biotech & Nutrition Shareholding Pattern

59.53%
0.05%
0.14%
37.09%
3.19%

About Emmessar Biotech & Nutrition

  • NSE Symbol
  • EMMESSA
  • BSE Symbol
  • 524768
  • Managing Director
  • Mr. Srinivasa Raghavan Mathurakavi Ayyangar
  • ISIN
  • INE634B01016

Similar Stocks to Emmessar Biotech & Nutrition

Emmessar Biotech & Nutrition FAQs

Emmessar Biotech & Nutrition share price is ₹34 As on 17 June, 2025 | 10:42

The Market Cap of Emmessar Biotech & Nutrition is ₹17 Cr As on 17 June, 2025 | 10:42

The P/E ratio of Emmessar Biotech & Nutrition is 53.7 As on 17 June, 2025 | 10:42

The PB ratio of Emmessar Biotech & Nutrition is 2.2 As on 17 June, 2025 | 10:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23